NEW YORK (AP) ¿ Mindray Medical International Ltd., a Chinese medical device company, reported a 55 percent profit increase in its third quarter, helped by a gain from the early termination of a contract. The company earned $43.4 million, or 38 cents per share, in the three months ended Sept. 30, up from $28 million, or 24 cents per share, a year ago. Revenue rose 3 percent to $151.1 million from $146.5 million. Excluding one-time items, the company said it earned 33 cents per share. Analysts polled by Thomson Reuters expected profit of 27 cents per share on higher revenue of $155 million. The company reported $11.8 million in other income in the latest quarter from an early contract termination. Shares of Mindray fell $2.09, or 6.1 percent, to $32 in midday trading. The stock has traded between $12.31 and $34.49 over the last 52 weeks.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Technology
Kass: 3 Spots of Vulnerability I Would Avoid in This Market
I suggest avoiding all three over the next few months and over the remainder of the year.
Amazon Is Headed to $3,000 a Share, Says Bullish Piper Jaffray Note
The firm estimates Amazon will cross $3,000 a share sometime between mid-2021 and mid-2022.
HPE's CFO Discusses Impact of Cloud Trends and Lower Memory Prices
During a talk with TheStreet right after its earnings report, CFO Tarek Robbiati talks about how HPE is trying to position itself as cloud infrastructure adoption continues, and what kind of boost it's getting from lower memory prices.
Buy Alibaba Shares on the Dip, Says Stifel, Adding It to Select List
Stifel says long-term trends working in Alibaba's favor are more significant than the trade war between the U.S. and China.